-
Recent Posts
- Opinion: Ethical Challenges in Using iPS Cells to Treat Paralysis
- Mechanisms of noradrenergic modulation of synaptic transmission and neuronal excitability in ventral horn neurons of the rat spinal cord
- Marquette receives $500,000 for research from the Bryon Riesch Foundation
- NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING
- Acteoside Improves Muscle Atrophy and Motor Function by Inducing New Myokine Secretion in Chronic Spinal Cord Injury
- Restoring function after severe spinal cord injury through bioluminescence-driven optogenetic stimulation of spinal circuitry
- Repositioning Flubendazole for Spinal Cord Injury
- Regenerative metabolic signaling after nerve and spinal injury
- Dr Jerry Silver – Spinal Cord Damage and Emerging Treatments
- Epigenetic regulation of axonal regeneration
- Tune into SCI 2020 tomorrow and Wednesday
- Engineered Neuroplasticity for Spinal Cord Rehabilitation
- A novel biomaterial-based Epac targeting approach to promote spinal cord repair
- Transplanting Cells for Spinal Cord Repair: Who, What, When, Where and Why?
- Stem Cell Therapy for Traumatic SCI
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: E. S. Rosenzweig
Continued development of human neural stem cell grafts into non-human primate spinal cord contusion or hemisection lesions
Authors: *E. S. ROSENZWEIG, J. H. BROCK, P. LU, H. KUMAMARU, J. L. WEBER, C. A. WEINHOLTZ, R. MOSEANKO, S. HAWBECKER, R. PENDER, C. L. CRUZEN, E. A. SALEGIO,, J. HUIE, C. ALMEIDA, Y. S. NOUT-LOMAS, L. A. HAVTON, A. … Continue reading
Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury
Lab Abstract: Inhibitory chondroitin sulfate proteoglycans (CSPGs) in the extracellular matrix hinder axonal regeneration after spinal cord injury (SCI). In particular, CSPGs form ‘peri-neuronal nets’ that may limit axonal regrowth and synaptic plasticity. Moreover, CSPGs are newly synthesized at sites … Continue reading
